Study identification

PURI

https://redirect.ema.europa.eu/resource/39968

EU PAS number

EUPAS35897

Study ID

39968

Official title and acronym

Inhaled corticosteroids and COVID-19 morbidity: Nationwide cohort study

DARWIN EU® study

No

Study countries

Denmark

Study description

Study of corticosteroids in COVID-19 in comparison with influenza.

Study status

Finalised
Research institution and networks

Institutions

Statens Serum Institut Copenhagen, Denmark

Contact details

Anders Husby

Primary lead investigator
Study timelines

Date when funding contract was signed

Actual:

Data collection

Actual:

Start date of data analysis

Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

Various Research councils
Study protocol
Initial protocol

COVID_19_inhaled_cs_PROTOCOL_FINAL_EUPAS_P

English (531.02 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable